ATE143364T1 - Funktionalisierte polyamin-chelatbildner, ihre komplexe und verfahren zu ihrer herstellung - Google Patents
Funktionalisierte polyamin-chelatbildner, ihre komplexe und verfahren zu ihrer herstellungInfo
- Publication number
- ATE143364T1 ATE143364T1 AT88109799T AT88109799T ATE143364T1 AT E143364 T1 ATE143364 T1 AT E143364T1 AT 88109799 T AT88109799 T AT 88109799T AT 88109799 T AT88109799 T AT 88109799T AT E143364 T1 ATE143364 T1 AT E143364T1
- Authority
- AT
- Austria
- Prior art keywords
- complexes
- production
- methods
- chelating agent
- functionalized polyamine
- Prior art date
Links
- 229920000768 polyamine Polymers 0.000 title abstract 2
- 239000002738 chelating agent Substances 0.000 title 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 abstract 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 abstract 1
- 150000003283 rhodium Chemical class 0.000 abstract 1
- 229910052703 rhodium Inorganic materials 0.000 abstract 1
- 239000010948 rhodium Substances 0.000 abstract 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C263/00—Preparation of derivatives of isocyanic acid
- C07C263/10—Preparation of derivatives of isocyanic acid by reaction of amines with carbonyl halides, e.g. with phosgene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0073—Rhodium compounds
- C07F15/008—Rhodium compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/065,739 US4994560A (en) | 1987-06-24 | 1987-06-24 | Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE143364T1 true ATE143364T1 (de) | 1996-10-15 |
Family
ID=22064774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88109799T ATE143364T1 (de) | 1987-06-24 | 1988-06-20 | Funktionalisierte polyamin-chelatbildner, ihre komplexe und verfahren zu ihrer herstellung |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US4994560A (de) |
| EP (1) | EP0296522B1 (de) |
| JP (1) | JP2728437B2 (de) |
| KR (1) | KR970011005B1 (de) |
| CN (1) | CN1022839C (de) |
| AT (1) | ATE143364T1 (de) |
| CA (1) | CA1341349C (de) |
| DE (1) | DE3855564T2 (de) |
| DK (1) | DK343288A (de) |
| ES (1) | ES2091746T3 (de) |
| FI (1) | FI101378B (de) |
| GR (1) | GR3021537T3 (de) |
| HU (1) | HU201333B (de) |
| IL (1) | IL86835A (de) |
| NO (1) | NO178928C (de) |
| NZ (1) | NZ225070A (de) |
| PT (1) | PT87802B (de) |
| ZA (1) | ZA884545B (de) |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132409A (en) * | 1987-01-12 | 1992-07-21 | Bracco Industria Chimica S.P.A. | Macrocyclic chelating agents and chelates thereof |
| US5006643A (en) * | 1987-06-24 | 1991-04-09 | The Dow Chemical Company | Process for preparing isothiocyanato functionalized metal complexes |
| CA1341373C (en) * | 1988-06-24 | 2002-07-02 | Roberta C. Cheng | Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| US5756065A (en) * | 1988-06-24 | 1998-05-26 | The Dow Chemical Company | Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents |
| ZA894792B (en) * | 1988-06-24 | 1991-04-24 | Dow Chemical Co | Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates |
| WO1990007261A2 (en) * | 1988-12-22 | 1990-07-12 | The Dow Chemical Company | Process for preparing mono-n-alkylated polyazamacrocycles |
| WO1990007342A1 (en) * | 1988-12-23 | 1990-07-12 | The Dow Chemical Company | Process for preparing isothiocyanato functionalized metal complexes |
| US5808003A (en) * | 1989-05-26 | 1998-09-15 | Perimmune Holdings, Inc. | Polyaminocarboxylate chelators |
| US5292868A (en) * | 1989-05-26 | 1994-03-08 | Akzo N.V. | Chelating agents for attaching metal ions to proteins |
| DE3930674A1 (de) * | 1989-09-11 | 1991-03-21 | Diagnostikforschung Inst | Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie |
| JP3131219B2 (ja) * | 1990-01-19 | 2001-01-31 | ニユコメド・イメージング・アクシエセルカペト | キレート化合物 |
| AU7587091A (en) * | 1990-03-26 | 1991-10-21 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A fonctionalized complexand |
| US5283293A (en) * | 1990-12-14 | 1994-02-01 | Corvas, Inc. | Reagents for automated synthesis of peptide analogs |
| GB9105489D0 (en) * | 1991-03-15 | 1991-05-01 | Johnson Matthey Plc | Improvements in chemical compounds |
| US5410043A (en) * | 1991-12-06 | 1995-04-25 | Schering Aktiengesellschaft | Process for the production of mono-N-substituted tetraaza macrocycles |
| DE4140779A1 (de) * | 1991-12-06 | 1993-06-09 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Verfahren zur herstellung von mono-n-substituierten tetraazamakrocyclen |
| GB9126677D0 (en) | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
| JPH07505886A (ja) * | 1992-04-13 | 1995-06-29 | ザ ダウ ケミカル カンパニー | マクロ環状キレート化剤の製造方法及びキレートの形成並びにその結合体 |
| US5310535A (en) * | 1992-04-24 | 1994-05-10 | The Dow Chemical Company | Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
| DE4218744C2 (de) * | 1992-06-04 | 1997-11-06 | Schering Ag | Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe |
| EP0588229A3 (en) * | 1992-09-12 | 1994-06-15 | Hoechst Ag | Macrocyclic chelating agents for the preparation of technetium or rhenium complexes |
| AU2194695A (en) * | 1994-03-28 | 1995-10-17 | Regents Of The University Of California, The | Method for preparing radionuclide-labeled chelating agent-ligand complexes |
| AU706642B2 (en) * | 1994-04-22 | 1999-06-17 | G.D. Searle & Co. | Diagnostic image analysis with metal complexes |
| JPH09512796A (ja) * | 1994-04-29 | 1997-12-22 | ザ キュレイターズ オブ ザ ユニヴァーシティー オブ ミズーリー | 治療用の放射性製薬のための二官能性キレート剤の調製に使用するチオエーテル化合物 |
| US7820798B2 (en) * | 1994-11-07 | 2010-10-26 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
| US7597886B2 (en) * | 1994-11-07 | 2009-10-06 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
| US5663161A (en) * | 1995-02-17 | 1997-09-02 | The Research Foundation Of State University Of New York | Anti-viral triaza compounds |
| WO1997001520A1 (en) * | 1995-06-28 | 1997-01-16 | E.I. Du Pont De Nemours And Company | Composition and method for stabilizing radiolabeled organic compounds |
| US5719033A (en) * | 1995-06-28 | 1998-02-17 | Motorola, Inc. | Thin film transistor bio/chemical sensor |
| EP0846003A1 (de) | 1995-08-17 | 1998-06-10 | Monsanto Company | Verfahren zur diagnostischen bildanalyse unter verwendung von biokonjugaten von metallkomplexen von stickstoffhaltigen makrocyclischen liganden |
| US5871436A (en) * | 1996-07-19 | 1999-02-16 | Advanced Cardiovascular Systems, Inc. | Radiation therapy method and device |
| US5782740A (en) * | 1996-08-29 | 1998-07-21 | Advanced Cardiovascular Systems, Inc. | Radiation dose delivery catheter with reinforcing mandrel |
| US6143849A (en) * | 1996-11-27 | 2000-11-07 | The United States Of America As Represented By The Secretary Of The Navy | Synthesis of acrylate and alkyl acrylate monomers and polymers of chelators |
| US6776792B1 (en) * | 1997-04-24 | 2004-08-17 | Advanced Cardiovascular Systems Inc. | Coated endovascular stent |
| US6210312B1 (en) | 1997-05-20 | 2001-04-03 | Advanced Cardiovascular Systems, Inc. | Catheter and guide wire assembly for delivery of a radiation source |
| US6159140A (en) * | 1998-02-17 | 2000-12-12 | Advanced Cardiovascular Systems | Radiation shielded catheter for delivering a radioactive source and method of use |
| US6224535B1 (en) | 1998-02-17 | 2001-05-01 | Advanced Cardiovascular Systems, Inc. | Radiation centering catheters |
| US6159139A (en) * | 1998-02-17 | 2000-12-12 | Advanced Cardiovascular Systems Inc. | Radiation delivery catheter with a spring wire centering mechanism |
| US6235363B1 (en) | 1998-05-06 | 2001-05-22 | Avery Dennison Corporation | Composite construction containing barrier layer |
| AU3501700A (en) | 1999-02-26 | 2000-09-14 | Human Genome Sciences, Inc. | Human endokine alpha and methods of use |
| US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
| US6605031B1 (en) | 1999-09-22 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Stepped centering balloon for optimal radiation delivery |
| US6582417B1 (en) * | 1999-09-22 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Methods and apparatuses for radiation treatment |
| US7994449B2 (en) | 2000-02-16 | 2011-08-09 | Advanced Cardiovascular Systems, Inc. | Square-wave laser bonding |
| US7163504B1 (en) | 2000-02-16 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Multi-lumen fluted balloon radiation centering catheter |
| EP2213743A1 (de) | 2000-04-12 | 2010-08-04 | Human Genome Sciences, Inc. | Albuminfusionsproteine |
| EP2431054A3 (de) | 2000-06-15 | 2013-03-06 | Human Genome Sciences, Inc. | Menschlicher Tumornekrosefaktor Delta und Ypsilon |
| PT2281843T (pt) | 2000-06-16 | 2017-01-02 | Human Genome Sciences Inc | Anticorpos que se ligam imunoespecificamente a blys |
| US6783793B1 (en) * | 2000-10-26 | 2004-08-31 | Advanced Cardiovascular Systems, Inc. | Selective coating of medical devices |
| US6764505B1 (en) * | 2001-04-12 | 2004-07-20 | Advanced Cardiovascular Systems, Inc. | Variable surface area stent |
| US7064189B2 (en) | 2001-05-25 | 2006-06-20 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to trail receptors |
| US7862495B2 (en) * | 2001-05-31 | 2011-01-04 | Advanced Cardiovascular Systems, Inc. | Radiation or drug delivery source with activity gradient to minimize edge effects |
| US6565659B1 (en) * | 2001-06-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Stent mounting assembly and a method of using the same to coat a stent |
| US6656216B1 (en) * | 2001-06-29 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Composite stent with regioselective material |
| DK1411918T3 (da) | 2001-07-31 | 2012-04-23 | Genzyme Global S A R L | Fremgangsmåder til at mobilisere progenitor/stamceller |
| US20080194481A1 (en) | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
| AU2002364586A1 (en) | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| AU2003218456A1 (en) * | 2002-04-01 | 2003-10-20 | Human Genome Sciences, Inc. | Antibodies that specifically bind to gmad |
| WO2003086458A1 (en) | 2002-04-12 | 2003-10-23 | Medimmune, Inc. | Recombinant anti-interleukin-9 antibodies |
| AU2003274463B2 (en) * | 2002-06-10 | 2009-10-29 | University Of Rochester | Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| US7169178B1 (en) * | 2002-11-12 | 2007-01-30 | Advanced Cardiovascular Systems, Inc. | Stent with drug coating |
| AU2003302254A1 (en) * | 2002-12-16 | 2004-07-22 | Avery Dennison Corporation | Analyte detecting article and method |
| US7198675B2 (en) * | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
| GB0416062D0 (en) * | 2004-07-19 | 2004-08-18 | Amersham Plc | Improved N4 chelator conjugates |
| AU2004296184B2 (en) * | 2003-12-04 | 2010-12-16 | Vaccinex, Inc. | Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| US7563324B1 (en) | 2003-12-29 | 2009-07-21 | Advanced Cardiovascular Systems Inc. | System and method for coating an implantable medical device |
| HUE027902T2 (en) | 2004-02-09 | 2016-11-28 | Human Genome Sciences Inc Corp Service Company | Albumin fusion proteins |
| US7973139B2 (en) * | 2004-03-26 | 2011-07-05 | Human Genome Sciences, Inc. | Antibodies against nogo receptor |
| US7553377B1 (en) | 2004-04-27 | 2009-06-30 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for electrostatic coating of an abluminal stent surface |
| US20050288481A1 (en) * | 2004-04-30 | 2005-12-29 | Desnoyer Jessica R | Design of poly(ester amides) for the control of agent-release from polymeric compositions |
| US7632307B2 (en) | 2004-12-16 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Abluminal, multilayer coating constructs for drug-delivery stents |
| US20060216431A1 (en) * | 2005-03-28 | 2006-09-28 | Kerrigan Cameron K | Electrostatic abluminal coating of a stent crimped on a balloon catheter |
| KR101443050B1 (ko) | 2005-05-06 | 2014-09-22 | 지모제넥틱스, 인코포레이티드 | Ｉｌ-31 단클론성 항체 및 사용법 |
| US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
| US20070148251A1 (en) * | 2005-12-22 | 2007-06-28 | Hossainy Syed F A | Nanoparticle releasing medical devices |
| NZ615012A (en) | 2006-03-21 | 2015-11-27 | Genentech Inc | Combinatorial therapy involving alpha5beta1 antagonists |
| US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
| US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
| US8048448B2 (en) * | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
| AU2007261247A1 (en) * | 2006-06-22 | 2007-12-27 | Vaccinex, Inc. | Anti-C35 antibodies for treating cancer |
| US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
| ES2548714T3 (es) | 2006-09-01 | 2015-10-20 | Zymogenetics, Inc. | Anticuerpos monoclonales IL-31 y procedimientos de uso |
| WO2008105473A1 (ja) * | 2007-02-28 | 2008-09-04 | National University Corporation Chiba University | 抗悪性腫瘍薬 |
| US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
| ME03057B (de) | 2007-12-07 | 2019-01-20 | Zymogenetics Inc | Für IL-31 spezifische humanisierte Antikörpermoleküle |
| CA2710680C (en) | 2007-12-26 | 2018-10-16 | Vaccinex, Inc. | Anti-c35 antibody combination therapies and methods |
| EP2382466B1 (de) | 2008-12-30 | 2016-03-09 | Children's Medical Center Corporation | Verfahren zur vorhersage einer akuten blinddarmentzündung |
| NZ594343A (en) | 2009-03-25 | 2013-10-25 | Genentech Inc | Novel anti-alpha5beta1 antibodies and uses thereof |
| WO2011044472A1 (en) * | 2009-10-08 | 2011-04-14 | Angus Chemical Company | Low-voc polyamines |
| US20110293629A1 (en) | 2010-05-14 | 2011-12-01 | Bastid Jeremy | Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 Antagonists |
| GB201008584D0 (en) * | 2010-05-22 | 2010-07-07 | Univ Warwick | Novel iridium anti-cancer compounds |
| US10384078B2 (en) * | 2013-10-15 | 2019-08-20 | Ip Liberty Vision Corporation | Polymeric radiation-sources |
| EP3613433B1 (de) | 2014-05-30 | 2022-01-05 | Shanghai Henlius Biotech, Inc. | Antikörper gegen den epidermalen wachstumsfaktor-rezeptor (egfr) |
| EP3029032A1 (de) * | 2014-12-05 | 2016-06-08 | Centre National de la Recherche Scientifique (CNRS) | Bifunktionelle Do2pa-Derivate, Chelate mit metallischen Kationen und Verwendung davon |
| WO2016161390A1 (en) | 2015-04-03 | 2016-10-06 | Eureka Therapeutics, Inc. | Constructs targeting afp peptide/mhc complexes and uses thereof |
| WO2016172485A2 (en) | 2015-04-24 | 2016-10-27 | Genentech, Inc. | Multispecific antigen-binding proteins |
| CA3037144A1 (en) | 2016-09-16 | 2018-03-22 | Shanghai Henlius Biotech, Inc. | Anti-pd-1 antibodies |
| EP3568468A4 (de) | 2017-01-12 | 2020-12-30 | Eureka Therapeutics, Inc. | Gegen histon-h3-peptid/mhc-komplexe gerichtete konstrukte und verwendungen davon |
| EP3615574A4 (de) | 2017-04-26 | 2021-02-24 | Eureka Therapeutics, Inc. | Spezifisch glypican 3 erkennende konstrukte und deren verwendung |
| EP3765522A4 (de) | 2018-03-14 | 2022-05-18 | Beijing Xuanyi Pharmasciences Co., Ltd. | Anti-claudin-18.2-antikörper |
| US11993661B2 (en) | 2018-06-18 | 2024-05-28 | Eureka Therapeutics, Inc. | Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof |
| CN112300279A (zh) | 2019-07-26 | 2021-02-02 | 上海复宏汉霖生物技术股份有限公司 | 针对抗cd73抗体和变体的方法和组合物 |
| CN110818795B (zh) | 2020-01-10 | 2020-04-24 | 上海复宏汉霖生物技术股份有限公司 | 抗tigit抗体和使用方法 |
| WO2022116877A1 (en) | 2020-12-02 | 2022-06-09 | Shanghai Henlius Biotech, Inc. | ANTI-GARP/TGFβ ANTIBODIES AND METHODS OF USE |
| KR20240122784A (ko) | 2021-12-17 | 2024-08-13 | 상하이 헨리우스 바이오테크, 인크. | 항-ox40 항체 및 사용 방법 |
| KR20240116755A (ko) | 2021-12-17 | 2024-07-30 | 상하이 헨리우스 바이오테크, 인크. | 항-ox40 항체, 다중 특이적 항체 및 이의 사용 방법 |
| CA3245762A1 (en) | 2022-03-25 | 2023-09-28 | Shanghai Henlius Biologics Co., Ltd. | ANTI-MSLN ANTIBODIES AND METHODS OF USE |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2803528C2 (de) * | 1977-03-09 | 1984-10-18 | Tabushi, Iwao, Kyoto | Schwermetallionen-Adsorbens und dessen Verwendung zum Adsorbieren von Schwermetallionen |
| US4622420A (en) * | 1980-03-18 | 1986-11-11 | The Regents Of The University Of California | Chelating agents and method |
| US4454106A (en) * | 1982-06-07 | 1984-06-12 | Gansow Otto A | Use of metal chelate conjugated monoclonal antibodies |
| US4479930A (en) * | 1982-07-26 | 1984-10-30 | Trustees Of The University Of Massachusetts | Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product |
| US4615876A (en) * | 1983-04-25 | 1986-10-07 | Curators Of The University Of Missouri | Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides |
| US4678667A (en) * | 1985-07-02 | 1987-07-07 | 501 Regents of the University of California | Macrocyclic bifunctional chelating agents |
| US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
| GB8603537D0 (en) * | 1986-02-13 | 1986-03-19 | Parker D | Conjugate compound |
| US5057302A (en) * | 1987-02-13 | 1991-10-15 | Abbott Laboratories | Bifunctional chelating agents |
| US5006643A (en) * | 1987-06-24 | 1991-04-09 | The Dow Chemical Company | Process for preparing isothiocyanato functionalized metal complexes |
-
1987
- 1987-06-24 US US07/065,739 patent/US4994560A/en not_active Expired - Fee Related
-
1988
- 1988-06-15 CA CA000569508A patent/CA1341349C/en not_active Expired - Fee Related
- 1988-06-17 NZ NZ225070A patent/NZ225070A/xx unknown
- 1988-06-20 DE DE3855564T patent/DE3855564T2/de not_active Expired - Fee Related
- 1988-06-20 ES ES88109799T patent/ES2091746T3/es not_active Expired - Lifetime
- 1988-06-20 AT AT88109799T patent/ATE143364T1/de not_active IP Right Cessation
- 1988-06-20 EP EP88109799A patent/EP0296522B1/de not_active Expired - Lifetime
- 1988-06-22 DK DK343288A patent/DK343288A/da not_active Application Discontinuation
- 1988-06-22 IL IL8683588A patent/IL86835A/en not_active IP Right Cessation
- 1988-06-23 PT PT87802A patent/PT87802B/pt not_active IP Right Cessation
- 1988-06-23 HU HU883188A patent/HU201333B/hu not_active IP Right Cessation
- 1988-06-23 NO NO882784A patent/NO178928C/no not_active IP Right Cessation
- 1988-06-23 FI FI883046A patent/FI101378B/fi not_active IP Right Cessation
- 1988-06-24 JP JP63155058A patent/JP2728437B2/ja not_active Expired - Fee Related
- 1988-06-24 KR KR1019880007673A patent/KR970011005B1/ko not_active Expired - Fee Related
- 1988-06-24 ZA ZA884545A patent/ZA884545B/xx unknown
- 1988-06-24 CN CN88104543A patent/CN1022839C/zh not_active Expired - Fee Related
-
1990
- 1990-11-28 US US07/619,153 patent/US5284644A/en not_active Expired - Lifetime
-
1996
- 1996-11-06 GR GR960402911T patent/GR3021537T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE143364T1 (de) | Funktionalisierte polyamin-chelatbildner, ihre komplexe und verfahren zu ihrer herstellung | |
| AT348779B (de) | Mattenbahn und verfahren zu ihrer herstellung | |
| AT367351B (de) | Weiche, voluminoese und saugfaehige papierbahn und verfahren zu ihrer herstellung | |
| DE3780560D1 (de) | Fuehler und verfahren zu dessen herstellung. | |
| DE3867724D1 (de) | Modifiziertes feinpulveriges polytetrafluoraethylen und verfahren zu seiner herstellung. | |
| DE3885946D1 (de) | Kompositstrukturen und Verfahren zum Herstellen derselben. | |
| DE3866744D1 (de) | Copolyaether-imide und verfahren zu ihrer herstellung. | |
| DE3768083D1 (de) | Am kettenende funktionalisierte polymere und verfahren zu ihrer herstellung. | |
| DE3780532D1 (de) | Amphoterische staerke und verfahren zu deren herstellung. | |
| DE3883916D1 (de) | Ausrichtverfahren für eine feuerleiteinrichtung und feuerleiteinrichtung zur durchführung des verfahrens. | |
| DE3881669D1 (de) | Waermeresistenter verbundkoerper und verfahren zu seiner herstellung. | |
| DE3878475D1 (de) | Organopolysiloxanemulsion und verfahren zu ihrer herstellung. | |
| DE3876275D1 (de) | Optischer koppler und verfahren zu dessen herstellung. | |
| DE3871063D1 (de) | Faser-wickel mit innenabzug und verfahren zum herstellen des wickels. | |
| DE3865927D1 (de) | Tetrahydroindazolyl-benzoxazine, verfahren zu deren herstellung und deren anwendung. | |
| DE3868668D1 (de) | Waermeisolierende motorstruktur und verfahren zu deren herstellung. | |
| DE3880287D1 (de) | Chlortrifluoraethylen-telomere und verfahren zu ihrer herstellung. | |
| DE3873223D1 (de) | Benzoxazinyl-triazol-oxide, verfahren zu deren herstellung und deren anwendung. | |
| DE3867957D1 (de) | Modifiziertes polytetrafluoraethylen und verfahren zu seiner herstellung. | |
| DE3868905D1 (de) | Verschleissteil und verfahren zu seiner herstellung. | |
| DE3872648D1 (de) | Alkanoylesterverbindungen, zwischenverbindungen dazu und verfahren zur herstellung. | |
| PT65350B (de) | 1-methyl-2-(phenyl-oxymethyl)-5-nitroimidazole und verfahren zu ihrer herstellung | |
| DE3869660D1 (de) | Ionomerzusammensetzung und verfahren zu ihrer herstellung. | |
| DE3776013D1 (de) | Peptidase und verfahren zu ihrer herstellung. | |
| DE3869474D1 (de) | Aralkylester und verfahren zu ihrer herstellung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |